HIV-protease inhibitors. [N Engl J Med. 1998] - PubMed

Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations. [J Infect Dis. 1999]
Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
Monno L, Appice A, Cavaliere R, Scarabaggio T, Angarano G. J Infect Dis. 1999 Aug; 180(2):568-71.
Review HIV disease treatment in the era of HAART. [Biomed Pharmacother. 1999]
Review HIV disease treatment in the era of HAART.
Bonfanti P, Capetti A, Rizzardini G. Biomed Pharmacother. 1999 Mar; 53(2):93-105.
Clinical benefits of resistance assay for HIV-specific protease inhibitors: when to check and in whom? [AIDS. 1999]
Clinical benefits of resistance assay for HIV-specific protease inhibitors: when to check and in whom?
Aizawa S, Gatanaga H, Ida S, Sakai A, Tanaka M, Takahashi Y, Hirabayashi Y, Oka S. AIDS. 1999 Jul 9; 13(10):1278-9.
Safe and effective use of combination antiretroviral treatment. [Acta Clin Belg. 1999]
Safe and effective use of combination antiretroviral treatment.
Colebunders R, Clumeck N, Florence E, Vandercam B, Van Wanzeele F, Van Wijngaerden E, Lacor P, Demonty J, De Wit S. Acta Clin Belg. 1999 Apr; 54(2):55-60.
Review HIV protease inhibitors. [AIDS. 1995]
Review HIV protease inhibitors.
Winslow DL, Otto MJ. AIDS. 1995; 9 Suppl A:S183-92.

HIV Protease Inhibitors: Effect on the Opportunistic Protozoan Parasites. [Open Med Chem J. 2011]
HIV Protease Inhibitors: Effect on the Opportunistic Protozoan Parasites.
Alfonso Y, Monzote L. Open Med Chem J. 2011; 5:40-50. Epub 2011 Mar 9.
Protease expression by microorganisms and its relevance to crucial physiological/pathological events. [World J Biol Chem. 2011]
Protease expression by microorganisms and its relevance to crucial physiological/pathological events.
Dos Santos AL. World J Biol Chem. 2011 Mar 26; 2(3):48-58.
HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos Santos. [World J Biol Chem. 2010]
HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos Santos.
Dos Santos AL. World J Biol Chem. 2010 Feb 26; 1(2):21-30.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

HIV-protease inhibitors.
HIV-protease inhibitors.
N Engl J Med. 1998 Apr 30 ;338(18):1281-92.

PubMed
Equipotentiality of thalamo-amygdala and thalamo-cortico-amygdala circuits in au...
Equipotentiality of thalamo-amygdala and thalamo-cortico-amygdala circuits in auditory fear conditioning.
J Neurosci. 1992 Nov ;12(11):4501-9.

PubMed
Neurolinguistic programming as an adjunct to other psychotherapeutic/hypnotherap...
Neurolinguistic programming as an adjunct to other psychotherapeutic/hypnotherapeutic interventions.
Am J Clin Hypn. 1990 Jan ;32(3):174-82.

PubMed
Insulin resistance and coronary heart disease.
Insulin resistance and coronary heart disease.
Curr Opin Lipidol. 1996 Aug ;7(4):217-26.

PubMed
Symptomless HIV infection after more than ten years.
Symptomless HIV infection after more than ten years.
Lancet. 1990 Feb 17 ;335(8686):425-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed